AMPHASTAR PHARMACEUTICALS IN
AMPH·03209R103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AMPH (AMPHASTAR PHARMACEUTICALS IN) is held by 118 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($106.2M), DIMENSIONAL FUND ADVISORS LP ($39.7M), STATE STREET CORP ($31.5M). Net institutional sentiment: Mixed.
118
Holders
Avg rating(27 Elite)
$563.9M
Total Value
44% (139)
Fund Consensus
58 buying - 73 selling
Who's Trading
InsiderZRZhou RongSell $256KDec 17, 2025
InsiderPFPetersen Floyd F.Sell $63KDec 12, 2025
InsiderPFPetersen Floyd F.Sell $45KDec 11, 2025
InsiderPKPRINS RICHARD KSell $113KNov 25, 2025
InsiderPFPetersen Floyd F.Sell $442KNov 13, 2025
InsiderPFPetersen Floyd F.Sell $14KOct 1, 2025
InsiderPFPetersen Floyd F.Sell $15KSep 2, 2025
13F: Insider & Congress:
Showing 1-20 of 139
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer